Clinical study of MRG-007
Latest Information Update: 03 Feb 2025
Price :
$35 *
At a glance
- Drugs MRG 007 (Primary)
- Indications Colorectal cancer; Gastrointestinal cancer; Pancreatic cancer
- Focus Adverse reactions; Pharmacokinetics
- 03 Feb 2025 New trial record